Cannabidiol Prevents Ovariectomy-Induced Thermoregulatory Dysfunction in Rats: A Preclinical Study on Menopausal Vasomotor Symptoms
Drugs and Drug Candidates · 18.04.2026 · 5 (2) · 26
DOI: 10.3390/ddc5020026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drugs and Drug Candidates, online erschienen am 18.04.2026. Verfasst von Vitória Leite Lages und 8 weiteren Autor:innen. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
Background/Objectives: Vasomotor symptoms (hot flashes) affect 70–80% of menopausal women, significantly impairing quality of life. Current treatments include hormone therapy, which is contraindicated for many patients, and non-hormonal alternatives with limited efficacy or adverse effects. Cannabidiol (CBD), a non-psychoactive phytocannabinoid, has emerged as a potential therapeutic candidate due to its interaction with the endocannabinoid system. This study aimed to investigate whether a standardized Cannabis sativa extract containing isolated CBD attenuates heat dissipation in ovariectomized rats, a preclinical model of estrogen deficiency.
Methods
Female Wistar rats were randomly assigned to sham-operated vehicle-treated (SHAM-V), ovariectomized vehicle-treated (OVX-V), or ovariectomized CBD-treated (OVX-CBD; 10 mg/kg/day, oral gavage) groups. Treatment began on postoperative day 2 and continued for 21 days. Tail-skin temperature, a surrogate marker of heat dissipation, was assessed by infrared thermography on day 14. Energy metabolism was evaluated by indirect calorimetry on day 21. Uterine weight was measured as a biomarker of estrogen depletion.
Results
Ovariectomy significantly increased tail temperature compared to SHAM-V. CBD treatment completely prevented this effect, with OVX-CBD animals exhibiting thermographic profiles similar to SHAM-V. Uterine atrophy was not reversed by CBD. No differences in the calorimetry parameter were observed among groups.
Conclusions
This study provides novel preclinical evidence that cannabidiol attenuates ovariectomy-induced heat dissipation in rats, without detectable effects on uterine weight or metabolic parameters. These findings suggest that CBD may represent a potential non-hormonal approach for the management of menopausal vasomotor symptoms; however, further studies are required to elucidate the underlying mechanisms and to determine its translational and clinical relevance.
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
Lages, V. L., Godinho, L. F., Guieiro, A. S., Trindade, T., Costa, B. O., Costa, J. M. M., Pereira, R. R. D. S., Magalhães, C. O. D. E., & Honorato-Sampaio, K. (2026). Cannabidiol Prevents Ovariectomy-Induced Thermoregulatory Dysfunction in Rats: A Preclinical Study on Menopausal Vasomotor Symptoms. Drugs and Drug Candidates, 5(2), 26. https://doi.org/10.3390/ddc5020026
Vancouver
Lages VL, Godinho LF, Guieiro AS, Trindade T, Costa BO, Costa JMM, et al. Cannabidiol Prevents Ovariectomy-Induced Thermoregulatory Dysfunction in Rats: A Preclinical Study on Menopausal Vasomotor Symptoms. Drugs and Drug Candidates. 2026;5(2):26. doi:10.3390/ddc5020026
BibTeX
@article{Lages2026,
author = {Lages, Vitória Leite and Godinho, Lourdes Fernanda and Guieiro, Alayanne Santos and Trindade, Thais and Costa, Bruna Oliveira and Costa, Joyce Mirlene Moreira and Pereira, Ramona Ramalho de Souza and Magalhães, Caíque Olegário Diniz e and Honorato-Sampaio, Kinulpe},
title = {Cannabidiol Prevents Ovariectomy-Induced Thermoregulatory Dysfunction in Rats: A Preclinical Study on Menopausal Vasomotor Symptoms},
journal = {Drugs and Drug Candidates},
year = {2026},
volume = {5},
number = {2},
pages = {26},
doi = {10.3390/ddc5020026}
}
EUVIMED